Eleven-year experience of low grade lymphoma in Korea (based on REAL classification)

Jee Sook Hahn, Yong Soo Kim, Yongchan Lee, Woo Ick Yang, Sang Yeal Lee, Chang-Ok Suh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Low grade lymphomas are malignancies of predominantly small lymphocytes that typically have long median survival periods due to low proliferative rates. It is considered an indolent disease, but patients with low grade lymphoma can almost never be cured with conventional treatment. New low-grade lymphoma entities have been classified by the International Lymphoma Study Group (ILSG) and are also categorized into the Revised European American Lymphoma (REAL) classification. The REAL classification utilizes a multiparameter definition of clinico-pathologic and biologic entities. According to this classification, we investigated the incidence, various clinical characteristics, treatment outcome and prognostic factors of low grade lymphoma. Many clinical characteristics of low grade lymphoma in Korea differed from those of Western countries, especially in the incidence, therapeutic outcome and prognostic factors. In Korea, although the general incidence of low grade lymphoma is relatively low, the relative number of mucosa-associated lymphoid tissue lymphoma (MALToma) is very high, and the overall survival rate is better than that reported of Western countries. Thus, further investigation on treatment outcome and prognosis of low grade lymphoma entities, other than mucosa-associated lymphoid tissue lymphoma, are warranted.

Original languageEnglish
Pages (from-to)757-770
Number of pages14
JournalYonsei medical journal
Volume44
Issue number5
DOIs
Publication statusPublished - 2003 Oct 30

Fingerprint

Korea
Non-Hodgkin's Lymphoma
Lymphoma
Marginal Zone B-Cell Lymphoma
Incidence
Survival Rate
Lymphocytes
Survival
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hahn, Jee Sook ; Kim, Yong Soo ; Lee, Yongchan ; Yang, Woo Ick ; Lee, Sang Yeal ; Suh, Chang-Ok. / Eleven-year experience of low grade lymphoma in Korea (based on REAL classification). In: Yonsei medical journal. 2003 ; Vol. 44, No. 5. pp. 757-770.
@article{ec1a54648c844289a79f8a8fbce7c625,
title = "Eleven-year experience of low grade lymphoma in Korea (based on REAL classification)",
abstract = "Low grade lymphomas are malignancies of predominantly small lymphocytes that typically have long median survival periods due to low proliferative rates. It is considered an indolent disease, but patients with low grade lymphoma can almost never be cured with conventional treatment. New low-grade lymphoma entities have been classified by the International Lymphoma Study Group (ILSG) and are also categorized into the Revised European American Lymphoma (REAL) classification. The REAL classification utilizes a multiparameter definition of clinico-pathologic and biologic entities. According to this classification, we investigated the incidence, various clinical characteristics, treatment outcome and prognostic factors of low grade lymphoma. Many clinical characteristics of low grade lymphoma in Korea differed from those of Western countries, especially in the incidence, therapeutic outcome and prognostic factors. In Korea, although the general incidence of low grade lymphoma is relatively low, the relative number of mucosa-associated lymphoid tissue lymphoma (MALToma) is very high, and the overall survival rate is better than that reported of Western countries. Thus, further investigation on treatment outcome and prognosis of low grade lymphoma entities, other than mucosa-associated lymphoid tissue lymphoma, are warranted.",
author = "Hahn, {Jee Sook} and Kim, {Yong Soo} and Yongchan Lee and Yang, {Woo Ick} and Lee, {Sang Yeal} and Chang-Ok Suh",
year = "2003",
month = "10",
day = "30",
doi = "10.3349/ymj.2003.44.5.757",
language = "English",
volume = "44",
pages = "757--770",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "5",

}

Eleven-year experience of low grade lymphoma in Korea (based on REAL classification). / Hahn, Jee Sook; Kim, Yong Soo; Lee, Yongchan; Yang, Woo Ick; Lee, Sang Yeal; Suh, Chang-Ok.

In: Yonsei medical journal, Vol. 44, No. 5, 30.10.2003, p. 757-770.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Eleven-year experience of low grade lymphoma in Korea (based on REAL classification)

AU - Hahn, Jee Sook

AU - Kim, Yong Soo

AU - Lee, Yongchan

AU - Yang, Woo Ick

AU - Lee, Sang Yeal

AU - Suh, Chang-Ok

PY - 2003/10/30

Y1 - 2003/10/30

N2 - Low grade lymphomas are malignancies of predominantly small lymphocytes that typically have long median survival periods due to low proliferative rates. It is considered an indolent disease, but patients with low grade lymphoma can almost never be cured with conventional treatment. New low-grade lymphoma entities have been classified by the International Lymphoma Study Group (ILSG) and are also categorized into the Revised European American Lymphoma (REAL) classification. The REAL classification utilizes a multiparameter definition of clinico-pathologic and biologic entities. According to this classification, we investigated the incidence, various clinical characteristics, treatment outcome and prognostic factors of low grade lymphoma. Many clinical characteristics of low grade lymphoma in Korea differed from those of Western countries, especially in the incidence, therapeutic outcome and prognostic factors. In Korea, although the general incidence of low grade lymphoma is relatively low, the relative number of mucosa-associated lymphoid tissue lymphoma (MALToma) is very high, and the overall survival rate is better than that reported of Western countries. Thus, further investigation on treatment outcome and prognosis of low grade lymphoma entities, other than mucosa-associated lymphoid tissue lymphoma, are warranted.

AB - Low grade lymphomas are malignancies of predominantly small lymphocytes that typically have long median survival periods due to low proliferative rates. It is considered an indolent disease, but patients with low grade lymphoma can almost never be cured with conventional treatment. New low-grade lymphoma entities have been classified by the International Lymphoma Study Group (ILSG) and are also categorized into the Revised European American Lymphoma (REAL) classification. The REAL classification utilizes a multiparameter definition of clinico-pathologic and biologic entities. According to this classification, we investigated the incidence, various clinical characteristics, treatment outcome and prognostic factors of low grade lymphoma. Many clinical characteristics of low grade lymphoma in Korea differed from those of Western countries, especially in the incidence, therapeutic outcome and prognostic factors. In Korea, although the general incidence of low grade lymphoma is relatively low, the relative number of mucosa-associated lymphoid tissue lymphoma (MALToma) is very high, and the overall survival rate is better than that reported of Western countries. Thus, further investigation on treatment outcome and prognosis of low grade lymphoma entities, other than mucosa-associated lymphoid tissue lymphoma, are warranted.

UR - http://www.scopus.com/inward/record.url?scp=0242575095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242575095&partnerID=8YFLogxK

U2 - 10.3349/ymj.2003.44.5.757

DO - 10.3349/ymj.2003.44.5.757

M3 - Article

VL - 44

SP - 757

EP - 770

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 5

ER -